Russo I, Griffith Brookles C, Barale C, Melchionda E, Mousavi A, Biole C
Int J Mol Sci. 2024; 25(7).
PMID: 38612792
PMC: 11011739.
DOI: 10.3390/ijms25073981.
Zhong P, Deng J, Zhao J, Peng L, Liu T, Wang H
Front Cardiovasc Med. 2023; 10:1079332.
PMID: 37025677
PMC: 10070678.
DOI: 10.3389/fcvm.2023.1079332.
Galli M, Angiolillo D
Front Cardiovasc Med. 2022; 9:975969.
PMID: 36093167
PMC: 9452742.
DOI: 10.3389/fcvm.2022.975969.
Angiolillo D, Galli M, Collet J, Kastrati A, ODonoghue M
EuroIntervention. 2022; 17(17):e1371-e1396.
PMID: 35354550
PMC: 9896394.
DOI: 10.4244/EIJ-D-21-00904.
Galli M, Franchi F, Rollini F, Cavallari L, Capodanno D, Crea F
Expert Rev Clin Pharmacol. 2021; 14(8):963-978.
PMID: 33993817
PMC: 9008593.
DOI: 10.1080/17512433.2021.1927709.
High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study.
Zhao X, Li Q, Tu C, Zeng Y, Ye Y
Cardiovasc Diabetol. 2020; 19(1):171.
PMID: 33036613
PMC: 7545941.
DOI: 10.1186/s12933-020-01146-w.
Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement.
Gorog D, Becker R
J Thromb Thrombolysis. 2020; 51(1):1-11.
PMID: 32529549
PMC: 7829242.
DOI: 10.1007/s11239-020-02170-z.
De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early?.
Masiero G, Rossini R
Eur Heart J Suppl. 2020; 22(Suppl E):E132-E136.
PMID: 32523457
PMC: 7270966.
DOI: 10.1093/eurheartj/suaa078.
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing.
Franchi F, Rollini F, Rivas J, Rivas A, Agarwal M, Briceno M
JACC Basic Transl Sci. 2020; 5(5):419-428.
PMID: 32478205
PMC: 7251226.
DOI: 10.1016/j.jacbts.2020.02.009.
[Platelet GPⅠb-Ⅸ-Ⅴ receptor-mediated mechanism and its application in thrombotic diseases].
Zhou X, Cheng Z, Hu Y
Zhonghua Xue Ye Xue Za Zhi. 2019; 40(6):532-536.
PMID: 31340631
PMC: 7342399.
DOI: 10.3760/cma.j.issn.0253-2727.2019.06.017.
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis.
Angiolillo D, Patti G, Chan K, Han Y, Huang W, Yakovlev A
J Thromb Thrombolysis. 2019; 48(1):1-10.
PMID: 31004312
PMC: 6556170.
DOI: 10.1007/s11239-019-01860-7.
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention.
Cavallari L, Franchi F, Rollini F, Been L, Rivas A, Agarwal M
J Transl Med. 2018; 16(1):92.
PMID: 29642909
PMC: 5896099.
DOI: 10.1186/s12967-018-1469-8.
